Literature DB >> 8435043

Sequence analysis of selected regions of the env (V3 loop and gp41) and gag (p7) reading frames of Ethiopian human immunodeficiency virus type 1 strains.

S Ayehunie1, B Johansson, A Sönnerborg, D W Zewdie, S Britton, O Strannegård.   

Abstract

Amplified polymerase chain reaction (PCR) products, corresponding to the V3 loop and gp41 of the env, and p7 of the gag region, from proviral DNA of several Ethiopian and Swedish HIV-1 strains were sequenced. Of the six amino acids (GPGRAF) that constitute the principal neutralizing determinant (PND) within the V3 loop, the Ethiopian isolates all showed two amino acid changes (GPGQTF). Four to five other substitutions were found in the amino acids flanking the PND. Substitution of alanine (A) for threonine (T) should result in a change in the predicted secondary structure, i.e., disappearance of a coil structure. Percentage similarity data on a stretch of 22 amino acids within the V3 loop showed a concordance of the Ethiopian HIV-1 isolates with the sequences of published macrophage-T-cell tropic HIV isolates. Additionally derived protein sequences in two other regions showed two common substitutions in p7 and one to two substitutions in gp41 compared to a recent consensus sequence. These changes are hitherto unique for the Ethiopian strains, and suggest the presence of a clustering of a divergent HIV-1 strain in Addis Ababa, Ethiopia.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Developed Countries; Developing Countries; Diseases; Eastern Africa; Ethiopia; Europe; Examinations And Diagnoses; Genetic Technics; Hiv Infections; Laboratory Examinations And Diagnoses; Laboratory Procedures; Northern Europe; Scandinavia; Sweden; Viral Diseases

Mesh:

Substances:

Year:  1993        PMID: 8435043     DOI: 10.1007/bf01309436

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  23 in total

1.  Long-term high-titer neutralizing activity induced by octameric synthetic HIV-1 antigen.

Authors:  C Y Wang; D J Looney; M L Li; A M Walfield; J Ye; B Hosein; J P Tam; F Wong-Staal
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

2.  Differences in PCR reactivity between HIV proviruses from individuals in Ethiopia and Sweden.

Authors:  S Ayehunie; A Sönnerborg; B Johansson; T E Fehniger; D W Zewdie; T Yeamane-Berhan; B Petros; J Abens; S Britton; O Strannegård
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

3.  New subtype of HIV-1 in Ethiopia.

Authors:  S Ayehunie; B Johansson; A Sönnerborg; M Salminen; D W Zewdie; T Fehniger; S Britton; O Strannegård
Journal:  Lancet       Date:  1990-10-13       Impact factor: 79.321

4.  Identification of conserved residues in the human immunodeficiency virus type 1 principal neutralizing determinant that are involved in fusion.

Authors:  E O Freed; R Risser
Journal:  AIDS Res Hum Retroviruses       Date:  1991-10       Impact factor: 2.205

5.  Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

Authors:  P W Berman; T J Gregory; L Riddle; G R Nakamura; M A Champe; J P Porter; F M Wurm; R D Hershberg; E K Cobb; J W Eichberg
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

6.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

7.  Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.

Authors:  G J LaRosa; J P Davide; K Weinhold; J A Waterbury; A T Profy; J A Lewis; A J Langlois; G R Dreesman; R N Boswell; P Shadduck
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

8.  Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.

Authors:  C F Scott; S Silver; A T Profy; S D Putney; A Langlois; K Weinhold; J E Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

9.  Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15.

Authors:  F D Veronese; R Rahman; T D Copeland; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  AIDS Res Hum Retroviruses       Date:  1987       Impact factor: 2.205

10.  Extensive variation of human immunodeficiency virus type-1 in vivo.

Authors:  M S Saag; B H Hahn; J Gibbons; Y Li; E S Parks; W P Parks; G M Shaw
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

View more
  2 in total

1.  Subtyping of human immunodeficiency virus type 1 strains by using antibodies specific for the third variable domain (V3) of gp120: results may be affected by divergent V3 sequences.

Authors:  K Sherefa; M Sällberg; B Johansson; M Salminen; A Sönnerborg
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Development of a nucleic acid sequence-based amplification assay that uses gag-based molecular beacons to distinguish between human immunodeficiency virus type 1 subtype C and C' infections in Ethiopia.

Authors:  Workenesh Ayele; Georgios Pollakis; Almaz Abebe; Bitew Fisseha; Belete Tegbaru; Girma Tesfaye; Yohannes Mengistu; Dawit Wolday; Bob van Gemen; Jaap Goudsmit; Wendelien Dorigo-Zetsma; Michel P de Baar
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.